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Abstract
Most patients who undergo cosmetic surgery do not report pain during the immediate 
postoperative period. However, most patients who underwent liposuction combined 
with or without other plastic surgical procedure suffer pain after surgery. There are three 
main techniques in acute pain management postoperatively which are systemic anal-
gesia, regional analgesia, and local/topical analgesia, and these are the extent of trauma 
during the procedure, surgeon’s skill, prior disease, location and type of incision, and 
psychological and cultural factors. Treatment for each type of plastic surgery and the 
resulting pain require techniques that can be used as single method or combined with 
each other to relieve postoperative pain after plastic surgery. Nausea, vomiting, constipa-
tion, somnolence, etc., are well-known adverse effects of opioids. Although these effects 
may seem minor, they can lead to significant complications following some type of plastic 
surgeries, for example, face-lift hematoma following nausea and vomiting, pulmonary 
complications from respiratory depression, and even thromboembolic phenomena from 
bed rest following prolonged opioid use. Multimodal pain management has been docu-
mented to increase patient satisfaction and reduce both opioid use and the incidence of 
PONV. Combination of pain management in plastic surgery included patient-controlled 
analgesia intravenous (PCA-IV), patient-controlled epidural analgesia (PCEA), patient-
controlled regional analgesia (PCRA), field block (TAP block), continuous wound infusion 
system using pain pump and tumescent analgesia with local anesthetics.
Keywords: postoperative pain, IV-PCA, PCEA, PCRA, field block, TAP block, 
tumescent analgesia, opioids, NSAIDs
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1. Introduction
Plastic surgery has become increasingly done over the last decades. The surgeon and patients 
become aware of the importance of postoperative pain control. This has occurred in part in 
an attempt to improve the patient experience and satisfaction. However, pain remains a major 
patient concern. Most patients who undergo cosmetic surgery do not report pain during the 
immediate postoperative period. However, most patients who underwent liposuction com-
bined with or without other surgical procedure report pain after surgery. Pain is unpleasant 
sensory and emotional experience associated with tissue injury [2]. Postoperative pain is mainly 
derived from acute tissue manipulation during the surgical procedure. In fact, a recent study 
documented that 30–80% of patients undergoing outpatient surgery encountered moderate-to-
severe postoperative pain. The characteristics of pain that should be evaluated are onset, loca-
tion, irradiation, type of pain, duration, and pain-related behavioral responses [2–4].
Along with this increased awareness of the importance for pain management, a variety of 
newer analgesics modalities designed to reduce pain have arrived on the scene. In the era 
of health care reformation, it is important to consider that pain management techniques can 
contribute to the overall value of care that is delivered to patients.
1.1. Concept of multimodal pain management
Treatment for each type of plastic surgery and resulted pain requires a specific approach 
and must be individualized to the patient. There are three main techniques for acute postop-
erative pain management: systemic analgesia, regional analgesia, and local/topical analgesia. 
Systemic analgesia can be given through intravenous injection, oral or rectal route, intramus-
cular, and skin patch. Regional analgesia technique can be divided into neuraxial analgesia 
and peripheral nerve block. Currently, pain management through intravenous injection or 
continuous neuraxial and peripheral nerve blocks is more controllable and safer since the 
invention of pain pump, which commonly use the principal of patient-controlled analgesia. 
Opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), mild analgesics, local anesthetics, 
etc., are all valuable in the multimodal pain management [4–6].
Nausea, vomiting, constipation, somnolence, etc., are well-known adverse effects of opioids. 
Although these effects may seem minor to some, they can lead to significant complications fol-
lowing certain types of plastic surgery, for example, face-lift hematoma following nausea and 
vomiting, pulmonary complications from respiratory depression, and even thromboembolic 
phenomena from bed rest following prolonged opioid use. In fact, a recent study documented 
adverse side effects in 17% of patients due to opioids. Most importantly, multimodal pain therapy 
including pharmaceutical agents mentioned above, long-acting local anesthetic preparations, and 
pain pumps may in large part replace isolated narcotic treatment of postoperative pain. This 
approach has been documented to increase patient satisfaction and reduce both opioid use and 
the incidence of nausea and vomiting in a large variety of nonfacial esthetic procedures. Although 
this multimodal treatment seems to have significant benefits, postoperative dosing becomes more 
complex, and adverse drug interactions and drug overdose become more likely [1–10].
There are some combinations that is proven to have a good effect in multimodal analgesia, 
such as paracetamol and NSAIDs, paracetamol with opioids, nonselective NSAIDs or selective 
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cyclooxygenase (COX)-2 inhibitors with opioids, and alpha-2-delta modulators (gabapentin 
and pregabalin) with opioids, N-methyl-D-aspartate (NMDA) antagonists ketamine and mag-
nesium, also alpha-2-agonists clonidine and dexmedetomidine with opioids. Combination of 
central neuraxial analgesia through epidural with NSAIDs proved favorable by suppressing 
stress response and suppressing pro-inflammatory factor [4–9].
2. Systemic analgesia
There are several systemic analgesic protocols to relieve postoperative pain in plastic surgery, 
but the IV administration of opioid and nonopioid analgesics is the most used. In the follow-
ing paragraphs, each one of these managements is described, being possible for the combina-
tion of the different alternatives of analgesia.
2.1. Oral administration
Postoperative pain management for ambulatory patients usually is treated with NSAIDs. This 
type of analgesics is the most important treatment for nociceptive pain. These kind of patients 
may also need a short-acting opioids such as hydrocodone, oxycodone, and acetaminophen. 
In immediate postoperative pain management, we prefer to use short-acting opioids rather 
than long-acting ones. However, if the patient is already on long-acting opioid before surgery, 
it is more appropriate to continue the long-acting opioid with combination of short-acting 
opioid for postoperative pain [3–9].
2.2. Intravenous bolus injection
Intravenous (IV) injection drugs that are commonly used as postoperative pain management 
are opioids (morphine and oxycodone). They are given based on patient’s need, usually for 
every 2–4 h. This condition can become a burden for both nurse and patient when the ratio 
between nurse and patient is low. NSAIDs also can be given intravenously for a short period, 
1–2 days [5, 7, 9, 11–13].
2.3. Intravenous patient-controlled analgesia (PCA-IV)
Patient-controlled analgesia (PCA) was used since 1971. PCA is one of the pain management 
techniques using a programmable pump intravenous device. The machine is put at patient’s 
bedside and connected to the IV line than contains a bag of premixed opioid solution. The 
patient can self-administer analgesic on demand by pressing the button connected to the PCA 
machine. The demand dose is already determined by the physician. The machine will lock for 
the amount of time before it can send another demand dose (lockout period), so it can protect 
the patient from overdosing. PCA device can also release the drug at a low-dose continu-
ous infusion rate [3]. There are several advantages of PCA such as painless route to deliver 
opioid, give accurate analgesia, help the nursing staff in patient’s pain control, and ensure 
the medication level compared with intermittent bolus injection or continuous IV infusion of 
opioid. PCA is used when the patient cannot take oral medication either in preoperative or 
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postoperative time or has nausea that causing the patient unable to take oral medication. PCA 
often use to control severe pain level such as burn injuries.
Minimal analgesia can be reached with opioid titration until minimum effective analgesia 
concentration (MEAC) can be reached, which becomes the border between pain and anal-
gesia. Furthermore, the dosage for causing analgesia varied among the patients and can be 
concluded that variability in opioid’s pharmacodynamic causes differences in the dosage. 
Individual MEAC can be determined by level of opioid endogen in preoperative cerebro-
spinal fluid. Patient with higher level of opioid endogen in cerebrospinal fluid needs lower 
MEAC to achieve and maintain the analgesia effect [3, 5, 7, 9, 11–15] (Figure 1).
In the figure above, X axis is the opioid plasma concentration and Y axis is the pain intensity 
from severe pain to no pain. Small circles show correlation between opioid concentration and 
pain intensity in an interval of increased opioid concentration. At the beginning, progressive 
increase of opioid concentration does not change pain intensity, but then with a little increase 
of opioid concentration, it can decrease pain intensity until pain is resolved. Increase of opioid 
concentration after this point will not give an extra effect.
2.3.1. PCA variable
PCA can be given in many methods, and the following two are the most common methods 
used in daily practice:
• Demand dose (the dosage has been made by the anesthetist and given by patient to him/
herself in a given period of time)
• Continuous infusion/background infusion along with demand dose in accordance with 
patient’s need.
Figure 1. Response to opioid concentration and pain intensity [17].
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2.3.1.1. Programmed intermittent bolus (PIB)
PIB is a specific dosage of drug that is programmed in PCA to give automatic bolus drug in 
specific intervals. PIB does not depend on demand dose or continuous infusion. PIB is usu-
ally used for epidural analgesia or peripheral nerve block analgesia. Time interval is around 
15–60 min, which means every for 15–60 min. PCA machine will automatically give bolus drug 
in a specific dose. For all PCA method, there are basic variables, such as: (a) initial bolus dose, 
(b) demand dose, (c) lockout interval, (d) Background infusion, (e) Maximum dose limitation 1 
and 4 h [15–19].
2.3.1.2. Initial bolus dose
It is possible to give drugs titration when activated by the program (not the patient). Initial 
bolus dose can be used by the nurse in postanesthesia care unit (PACU) to titrate opioid dose 
until reach MEAC or by the nurse at ward to administer the extra dose for the breakthrough 
pain. Initial bolus dose is the key for the success in pain management using PCA. Without it, 
there is a big possibility that pain may not be resolve adequately and patient can be disap-
pointed using the PCA machine [15–19].
2.3.1.3. Demand dose
Demand dose is also known as incremental dose or PCA dose. It is amount of analgesia that is 
given to the patient when patient press the demand button. PCA dose aims to maintain opioid 
level in MEAC level. PCA dose is the maintenance dose [15–19].
2.3.1.4. Lockout interval
To prevent opioid overdose with continuous demand, all PCA machines use lockout interval. 
It gives time lapse after administration of demand dose, and the machine will not respond to 
any demand dose, even though patient press the button, until certain time. This is one of the 
security systems in the PCA machine [15–19].
2.3.1.5. Background infusion
Infusion with constant speed is given without considering the patient’s demand. Back-
ground infusion is seldom used for patients with acute pain because of risk of overdose. 
Background infusion is usually administered to the patients who use opioid with large dose 
previously. Background infusion can be given by electrical PCA machine. Continuous infu-
sion used as adjuvant in administration of bolus dose can increase analgesia effect for the 
patient, so they can sleep without any disturbance due to pain. Disadvantages from this 
system are that opioid could still be given without considering the sedation level and can 
increase the risk of respiratory depression. Routine use of background infusion is not rec-
ommended. Background infusion may be useful in patients who are tolerant toward opioid, 
patients who are common in using opioid and need higher dose, or patients who have sleep 
disturbance at night due to pain [15–19].
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2.3.1.6. Maximum dose limitation
Some machine may have time limit 1 or 4 h. This program limits patient interval either 1 or 
4 h to get total cumulative dose. Usage of the interval 1 or 4 h is controversial. Prolimitation 
said that the limitation could give better security, while the contra side said there is no 
evidence that shows this limitation could give better security. In the other hand, if patient 
needs demand dose or PCA dose in large amount until it reaches the limitation for 1 or 
4 h, may be they really need that much dose to resolve the pain; thus, it is not necessary 
to reach that need. The usual maximum dose for morphine is 10 mg in 1 h or 30 mg in 
4 h. Keep in mind that PCA is used as maintenance therapies and pain should be under 
controlled before PCA is started. Disadvantages of this system are that opioid could still 
be given without considering the sedation level and can increase the risk of respiratory 
depression [15–19] (Figure 2).
2.4. Opioid for IV-PCA
Knowledge about pharmacology is the basic to use PCA effectively. A physician should 
understand not only indication and contraindication, but also pharmacodynamic and phar-
macokinetic of opioid, including absorption, distribution, biotransformation, and elimination 
from many types of opioid. Besides that, a doctor needs to understand specific physiologic 
response that can be happened when a drug binds to specific receptor inside or outside the 
Figure 2. Comparison between plasma drug concentration and their administration. Plasma drug concentration after 
small frequent dose PCA administration compared with large dose intramuscular or intravenous administration  every 
2-4 hours and continuous infusion intravenous. Ideally, plasma drug concentration is constant in analgesia range 
without any surge of plasma drug concentration that lead to over sedation and respiratory depression or low level of 
drugs that cause inadequate analgesia. Small but frequent dose could be reached by PCA.
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brain. Knowledge about all of the above will become essential to choose the right opioid that 
can be used in the PCA system. Parenteral opioid has three characters when binding with 
micro-opioid pure agonist, agonist-antagonist, and partial agonist. Character of pure agonist 
is the mainstay in acute pain management because can give full binding to microreceptor, 
and there is no maximal limit of analgesia (more opioid titration will give better effect in 
resolving pain.) However, there is a clinical maximal limitation that can give adverse effects 
such as sedation, respiratory depression, and often limit extra dose before reaching adequate 
level of analgesia. microagonist opioids are also effective in equianalgesic dose (i.e., 10 mg 
morphine = 2 mg hydromorphone = 100 mg meperidine) [15–19].
There are no significant differences in adverse effects due to opioids, even though patient 
can develop nausea, vomiting, or pruritus with one opioid, but not with other opioid drugs. 
All µ agonist decrease intestine movement, that contribute in ileus paralytic after surgery 
[15, 16, 18, 20].
Agonist-antagonist opioids activate κ receptor and antagonist toward microreceptor. Even 
though they are used with maximal effect limitation toward respiratory depression, it can 
give a wider safety margin, and this effect can happen with very large dose comparing it 
with microagonist. The most important thing is that agonist-antagonist has maximal limit 
of analgesic effect, so this group cannot make better analgesia compared with microagonist. 
Furthermore, agonist-antagonist drugs will induce acute withdrawal response in patients who 
receive microagonist opioids before. Due to activation of σ receptor, this group often induces 
psychotomimetic adverse effects. These type of opioids are uncommon to be used in PCA IV 
[15, 17, 18].
All opioids have been used successfully for PCA intravenous analgesia, with morphine as the 
most substance to be studied. Whatever opioid is chosen for intravenous PCA, knowledge 
about pharmacology is needed to control variable dose in PCA machine. Key component 
for effective PCA therapy is the right titration to get analgesia. Loading dose of morphine is 
2–4 mg (or equianalgesic dose for alternative opioid) given every 5–10 min in postanesthesia 
care unit (PACU) until pain score ≤4 from 10 or if respiratory rate <12 times per minute, which 
will give limitation for the next opioid administration. It should become a consideration to 
use multimodal therapy to achieve optimal analgesia and to decrease the use of opioid and 
will decrease the possibility of adverse effect and respiratory depression (Table 1).
Opioid Concentration Demand dose Lockout (min) Continuous basal
Morphine 1 mg/ml 1–2 mg 6–10 0–2 mg/h
Fentanyl 10–20 μg/ml 20–50 µg 5–10 0–60 µg/h
Sufentanil 1–4 μg/ml 4–6 µg 1–10 0–8 µg/h
Hydromorphone 0.1–0.2 mg/ml 0.2–0.4 6–10 0–0.4 mg/h
Tramadol 10–20 mg/ml 10–20 mg 6–10 0–20 mg/h
Oxycodone 1–2 mg/ml 1–2 mg 5–10 0–2 mg/h
Continuous infusion is not recommended in early design.
Table 1. Common PCA regimen.
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Figure 3. Simplified algorithm of IV-PCA management for basic setting of IV-PCA with morphine.
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2.4.1. Initial dose and adjusted dose
There is no ideal dose in IV-PCA. Deciding dose for PCA depends on patient and expected 
postoperative pain. The key component of effective PCA therapy is initial titration to achieve 
pain-free condition or minimal pain before starting the IV-PCA program. One consideration 
is that multimodal therapy approach must start early to optimize the analgesia and decrease 
the need of opioid, so can decrease the adverse effect and respiratory depression. Pain man-
agement with PCA will fail if initial analgesia cannot be achieved. This condition will disap-
point the patient who still feels pain even though the machine has been started. Patient will 
be frustrated and refuse to use PCA. Keep in mind that basic principle of PCA is to maintain 
the analgesia in optimal range for the patient [15, 17, 18] (Figure 3).
3. Regional analgesia
Analgesia with regional techniques has been fashionable due to its advantages: effective, safe, 
economical, and easy to perform. There are numerous techniques of perioperative analge-
sic blocks, which have benefited with the advent of ultrasound. The following paragraphs 
describe some procedures.
3.1. Central neuraxial analgesia
3.1.1. Patient-controlled epidural analgesia (PCEA)
Epidural analgesia is a safe and effective method to handle pain in any patient. It can be 
used for babies, children, adult, elderly in a short period (hours until days) or long period 
(weeks until months). Epidural analgesia can give superior regional analgesia compared 
with conventional systemic route (IV or oral) with minimum systemic side effect (nausea, 
sedation, or constipation). Drugs in epidural space are distributed through three main 
routes: (1) diffusion process through dura to cerebrospinal fluid, then to spinal cord or nerve 
root, (2) through uptake in epidural space blood vessel into systemic circulation, and (3) fat 
uptake of drug in epidural space where it can enter cerebrospinal fluid or systemic circula-
tion. Epidural analgesia insertion can be combined with PCA machine to reduce pain with 
patient as the controller, which is known as patient-controlled epidural analgesia (PCEA). 
PCEA is an effective method to control pain with analgesia and local anesthesia through a 
catheter inside the epidural space connected with a pain pump that delivers small dose of 
drugs directly to the epidural space. Unlike systemic administration, drugs that are injected 
into the epidural space are potent because it is close to the opioid and alpha agonist recep-
tors in dorsal horn. Due to small dose, the side effects are minimum such as nausea, seda-
tion, and respiratory depression. Usage of this method is usually seen in obstetric surgery 
and postsurgery pain management for lower abdomen, thoracic, and cancer pain or chronic 
pain management. Currently, there are two main methods in PCEA usage such as demand 
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dose only (PCEA dose) and continuous infusion with demand dose (PCEA + continuous 
infusion). Continuous infusion is an administration of drug with constant speed, without 
any consideration of patient’s need. When the pain increases for some reason, activation of 
demand dose will cause administration of extra small dose that increases the drug’s volume 
and the patient will be pain free. Some of PCEA machines make it possible for doctor to 
set other parameters in administration of drugs that is known as programmed intermittent 
epidural bolus (PIEB) [21–28] (Table 2).
Best pain management using epidural analgesia can be reached with combination of local 
anesthetic and opioid because they can work synergistic to decrease pain with fewer side 
effects than with single drug. All drugs and fluid that are injected into the epidural space 
should be free from preservative to avoid central nervous system toxicity [6].
The American Society of Anesthesiologist (ASA) published a clinical practice guidance to 
prevent infection from epidural analgesia. They recommend insertion of epidural catheter 
with aseptic technique, such as washing hand, sterile gloves, sterile gown, mask (used to 
cover mouth and nose), skin preparation, and sterile drapes around injection site. The tip of 
the epidural catheter should be placed based on the surgical dermatomes. Catheter should be 
fixed to minimize possibility of catheter misplace outside from the epidural space, migrate to 
subarachnoid space, or even migrate to a blood vessel. Dressing is adjusted so it will not cover 
the insertion. Nosocomial infection should be considered, and the use of prophylactics antibi-
otics is recommended, especially for patients with risk of infection (i.e., diabetics, patient who 
received steroid therapy or immunosuppression and patient who are hospitalized more than 
48 h with epidural catheter) [29] (Tables 3 and 4).
Before PCEA is started, a loading dose should be administered to reach the initial block 
level using higher concentration of local anesthetic than the concentration in PCEA solution. 
Continuous rate for adult patients needs adjustment depending on patient’s need. Continuous 
infusion is usually not used in PCEA [21–27] (Table 5).
3.2. Peripheral nerve blocks
Nerve block with local anesthetic in a specific location at or around the main nerve will depo-
larize the nerve and obtund the pain sensation in that specific area. Advantages of nerve block 
such as single accurate injection can block larger area of sensation without tissue distortion 
at the operative site. In the other hand, this method has the disadvantage of the sensation of 
Surgery site and injury Epidural insertion
Thoracic T4-T8
Upper abdomen T7-T10
Lower abdomen T9-L1
Hip and lower extremities L1-L4
Table 2. Epidural insertion based on surgery site.
Anesthesia Topics for Plastic and Reconstructive Surgery110
Opioid Concentration Loading 
dose*
PCEA 
dose*
Lockout 
interval 
(min)
Continuous 
rate*
4 h limitation 
(ml)
Morphine 50 µg/ml 2–4 mg 2–4 ml 10–15 6–12 ml/h 40–70
Hydromorphone 10 μg/ml 500–1500 μg 2–4 ml 6–10 6–12 ml/h 40–70
Fentanyl 2–5 µg/ml 75–100 μg 2–4 ml 6 6–15 ml/h 40–70
Sufentanil 2 µg/ml 0.5 µg/kg 2–4 ml 6 0.1 μg/kg/h 40–70
*Depend on epidural catheter insertion, surgery condition, and patient’s physical status.
Table 3. Opioid dose of PCEA guideline.
Incision site Analgesia solution Continuous 
infusion (ml/h)
Demand 
dose (ml)
Lockout 
interval 
(min)
PIEB (ml every)
Volume 
(ml)
Time 
(min)
Common 
Regimen
0.05% bupivacaine + 2–5 μg/
ml fentanyl
4–10 2–6 10–15 — —
0.0625% bupivacaine + 
2–5 μg/ml fentanyl
4–10 3–5 10–15 6–10 30–60
0.1% bupivacaine +2–5 μg/ml 
fentanyl
6–8 2–3 10–20 10 60
0.125% bupivacaine + 
0.05–0.1 mg/ml morphine
4–6 5–10 15–20 — —
0.0625–0.125% 
levobupivacaine + sufentanil 
0.5 µg /ml
10 5 10–15 10 60
0.1% levobupivacaine + 
fentanyl 2 μg/ml
10 5 10–15 5–10 30–60
0.1–0.2% ropivacaine + 
2–5 μg/ml fentanyl
3–5 2–5 10–20 5
2.5
30
15
Thoracic 0.0625–0.125% bupivacaine + 
2–5 μg/ml fentanyl
3–4 2–3 10–15 — —
Abdominal 0.0625% bupivacaine 
+2–5 μg/ml fentanyl
4–6 3–4 10–15 — —
0.125% bupivacaine + 0.5 μg/
ml sufentanil
3–5 2–3 10–15 — —
0.1–0.2% ropivacaine + 
2–5 μg/ml fentanyl
3–5 2–5 10–15 — —
0.125% bupivacaine + 
0.05–0.1 mg/ml morphine
4–6 10 15–20 — —
Lower extremity 0.0625–0.125% bupivacaine 
+2–5 μg/ml fentanyl
4 2 10–15 — —
Table 4. PCEA regimen for acute postsurgery pain.
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numbness in areas other than the operative site and unpredictable effect due to individual 
anatomic variation [6–30].
Regional anesthesia can be given as continuous block and demand dose using patient-con-
trolled regional anesthesia (PCRA). Commonly, PCRA is used in brachial plexus block, sciatic 
nerve block, and femoral nerve block. PCRA can decrease the consumption of local anesthesia 
without increasing the pain and high satisfaction level of patient who has undergone total 
hip or knee arthroplasty compared with continuous infusion. This method should be able to 
reduce motor block, minimize block of sensory, and better control from breakthrough pain 
[30–32]. The recommendation for PCRA setting is low basal infusion rate with 4–6 ml/h. for 
lower extremity and 6–10 ml/h. for upper extremity along with 2–10 ml small bolus doses 
with 20–60 min lockout interval [5, 31–35].
3.2.1. Drug of choice
All local anesthetics can be used, although the common choice is the short-acting drugs such 
as lidocaine and prilocaine. Tachyphylaxis has been reported and this condition is associated 
with occasional cyanosis caused by methemoglobinemia. Perhaps, it is for this reason that the 
drug is less favored. Bupivacaine, levobupivacaine, and ropivacaine have all been used for 
continuous peripheral nerve block (CPNB), but in general, there is no enough data available 
to suggest the best local anesthetic. Some experts suggest that ropivacaine is preferred because 
it has the capacity to maintain motor function. Casati preferred ropivacaine compared to lido-
caine for this reason. However, the evidence for this CPNB difference is limited and varied. For 
example, 0.2% ropivacaine provides the same pain relief rate when used in interscalene CPNB 
after shoulder surgery when compared with 0.15% bupivacaine or 0.11% levobupivacaine, but 
greater motor blockade is obtained. Comparison between bupivacaine and levobupivacaine 
was not found to be a significant difference. Similar studies doubled the concentration of these 
drugs (0.25% levobupivacaine compared with 0.25 and 0.4% ropivacaine) showing that anal-
gesia and motor block effects for interscalene catheters were similar at 0.25% levobupivacaine 
and 0.4% ropivacaine, but better than 0.25% ropivacaine. In a popliteal infusion study, Casati 
et al. also showed that 0.125% levobupivacaine was roughly equivalent to 0.2% of ropivacaine, 
either from analgesia or motor block sparing effect [33–39].
The term “analgesic gap” has been used for periods of inadequate analgesia that often occur 
after the loss of the initial block effect associated with catheter placement, but before subsequent 
local anesthetic infusions produce full effect. It may be especially difficult to treat if the patient 
is discharged after an outpatient operation with a catheter and infusion system. Keep in mind 
Type of surgery Catheter location Continuous infusion rate (ml/h)
Thoracic T2-T9 4–10
Upper abdominal T4-L1 4–10
Lower abdominal T10-L3 8–18
Lower extremity T12-L3 8–18
Table 5. Common continuous infusion rates for epidural analgesia.
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that regular oral analgesia should be started before the block runs out, and additional analgesia 
is readily available and used as early as the patient begins to feel uncomfortable with the pain.
Despite the recently published preclinical evidence of perineural pregabalin infusions and 
addition of clonidine, dexamethasone, and buprenorphine in perineural bupivacaine injected 
in mice, these data are still premature and until now there has been no drug other than local 
anesthesia approved by the FDA for continuous perineural administration. Randomized con-
trolled clinical trials have failed to show the advantage of adding clonidine or epinephrine to 
perineural infusions. There are sporadic RCTs that show the benefits of some opioids in peri-
neural infusions, but all these studies lack the active systemic control group that cannot assess 
the importance of perineural vs. intravenous opioid drug delivery. On the other hand, the addi-
tion of opioids often leads to an increased incidence of opioid-related side-effects. Recent data 
support previous evidence showing that total doses, not concentration/volume, are a major 
factor affecting clinical effects for continuous infusion of peripheral nerves [33, 35, 38–40].
3.2.2. PCRA brachial plexus
Insertion of brachial plexus catheter is generally divided into four parts: interscalene, supra-
clavicular, infraclavicular, and axillary. Choosing the right location for the insertion of the 
catheter in certain surgical procedures is of great importance compared to considering the 
variety of anesthesia techniques to be used.
3.2.2.1. PCRA axillary nerve block
After elective surgery on the hands, continuous axillary blocks using 0.1 or 0.2% ropivacaine 
did not have a better effect when compared to a control group using saline, and both groups 
still need additional analgesia. However, both in the continuous group and the recurrent 
bolus dose group using the 0.25% bupivacaine regimen gave better results in relieving pain 
with no difference in the two groups with the different techniques, either on the pain score, 
motor block degree, or on opioid requirements, although plasma bupivacaine levels were 
higher in the continuous group. Both 0.125% bupivacaine and 0.125% ropivacaine, given as a 
10-ml patient-controlled bolus dosage in outpatients, can relieve pain equally well. In addi-
tion to pain relief, continuous axillary block can provide an increased effect of vascular flow 
in patients after fingers reimplantation surgery [33, 39, 41].
3.2.2.2. PCRA brachial plexus periclavicular (supraclavicular/infraclavicular)
The periclavicular area has the advantage for the placement of a brachial plexus catheter. 
Unlike the axilla, this area is cleaner and relatively with less movement. With the increasing 
popularity of the infraclavicular block, various approaches of plexus catheterization are also 
increasingly used. The infraclavicular catheter has been widely used to relieve postoperative 
pain in the arms, elbows, and hands, even in patients undergoing outpatient treatment. Ilfeld 
et al. compared the use of ropivacaine infusions in the infraclavicular brachial plexus com-
pared with normal saline use in patients undergoing postsurgical upper-limb care treatment; 
patients receiving ropivacaine infusions experienced fewer pain complaints, fewer sleep dis-
turbances, and used less opioids, resulting in fewer opioid side effects, and higher patient 
satisfaction [31, 33, 39, 42].
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3.2.2.3. PCRA interscalene brachialis
Shoulder surgery can be very painful. Early and effective rehabilitation is important in 
improving postoperative outcomes. Given the substantial restriction of rehabilitation, it may 
not be surprising that the subject of local anesthetic infusion through the interscalene catheter 
is a new discussion in the literature on continuous peripheral nerve blocks and their use for 
pain relief following major surgery on the shoulders that has been widespread. The growing 
evidence now confirms that, in general, continuous interscalene brachial plexus may provide 
superior analgesia than intravenous opioids. For example, patient-controlled interscalene 
analgesia or continuous infusion of interscalene analgesia may ease pain, increase patient 
satisfaction, reduce opioid side effects compared with analgesia with IV-PCA and oral opioid 
analgesia. Interscalene analgesia also eases pain better and reduces opioid need after shoulder 
surgery compared with single injection interscalene block and infusion of local anesthesia 
into the glenohumeral joint or subacromial bursa, although mild adverse events may increase. 
For the record, it is worth mentioning that the most popular skin area for catheter access 
placement to the interscalene brachial plexus is also relatively mobile. For this reason, some 
anesthesiologists who use this technique will direct the catheter to the skin that is not moving 
much using tunneling technique [31, 33–35, 37, 39, 43–45].
3.2.2.4. Regimen dose
Some experts have used a number of different infusion strategies, ranging from simple con-
tinuous infusion rates, or controlled by patients, intermittent dose of bolus on demand only, 
to a combination of the two. The optimal local anesthetic regimen for CPNB is a combina-
tion of continuous infusion and patient-controlled bolus dosage which is known as patient 
controlled regional analgesia (PCRA). Grossi and Allegri and several other studies concluded 
that the best infusion regimen is a combination of continuous basal infusion with minimal 
rate, along with an intermittent bolus on demand that would otherwise result in a lower total 
local anesthetic use, than a continuous infusion course at a rate relatively with high infusion 
with equally effective analgesia results. There is insufficient evidence for optimal infusion 
rates, bolus doses on demand, or lockout intervals, although continuous infusion rates of 
4–10 ml/h, bolus dose on demand 2–5 ml, and 20–60 min lockout interval have been suc-
cessfully used. However, there will always be variations between patients, and the regimen 
should be adjusted to give the desired effect [33, 35, 37, 39, 41–46].
Currently, no known maximum safe dose for long-acting local anesthetics is administered 
continuously or via PCRA. In some studies, involving patients without kidney or liver dis-
ease, perineural infusions for 5 days with scheduled times indicate that the concentration 
of the drug in the blood is at a safe level. Administration of bupivacaine may be considered 
at a maximum infusion rate of 0.5 mg/kg/h based on predictions from data of patients 
receiving epidural bupivacaine infusion. Patients undergoing shoulder surgery using 
an interscalene catheter, supplemental block with large bolus dose (6 ml) can decrease 
continuous infusion rate from 8 to 4 ml/h and may prolong the duration of the infusion. 
However, many incidents and increased intensity of breakthrough pain, sleep disorders, 
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and decreased pain management satisfaction were reported. Therefore, if outpatients do 
not regain control to obtain additional local anesthesia, practitioners experience a dilemma 
regarding the use of analgesia selected between strong analgesia for a shorter period of 
time or weaker analgesia for a longer period of time. For the record, the duration of the 
infusion may be increased by progressively decreasing the basal infusion rate with a pro-
grammable infusion pump, thereby theoretically maximizing postoperative analgesia [33, 
35, 37, 39, 41–46].
Different results in doses of drug regimens can be caused by various factors, such as catheter 
design (no stimulation vs. stimulation), catheter placement (ultrasound vs. stimulation vs. 
combination) techniques, local anesthetic types (ropivacaine vs. bupivacaine vs. levobupiva-
caine) and concentration, infusion basal rate, bolus volume, lockout interval, operating proce-
dures, yield evaluation, measurement sensitivity, and many other factors. As a result, there is 
no evidence-based regimen that is ideal, although researchers have provided clinical recom-
mendations. However, there are some clinical situations where bolus dose administration is 
theoretically useful such as increasing block strength before wound care or potentially painful 
physical therapy. An RCT study showed that bolus on demand at PCRA reduced the need for 
local anesthesia. This provides three possible advantages: (1) theoretically reduces the motor 
block by decreasing the required basal infusion rate (to date, there is insufficient research), (2) 
reducing the incidence of numbness in the extremities, and (3) increasing the duration of the 
infusion/analgesia for outpatients who are dismissed from hospital with predetermined local 
anesthetic reservoir volume [31, 33, 37, 39, 43, 44, 46].
Some patients, especially the geriatrics, will experience a decrease in postoperative cognitive 
impairment. Therefore, most practitioners provide education to patients with their family/
caregiver. They should be given oral and written instructions, along with contact numbers 
of health workers who can be contacted. In addition to standard outpatient instructions, the 
items described include the after effects of anesthesia, instructions on the infusion pump, 
management of breakthrough pain, care of peripheral nerve catheters, the protection of limbs, 
and plans for catheter release. In addition, it is necessary to inform the onset of pain in the 
operative limb after the loss of peripheral nerve block effects, the possibility of fluid leakage 
at the site of the catheter and its treatment, and possible complications such as nerve injury, 
local infection, toxicity of local anesthetics, and pulmonary disorders. One variation of the 
technique that recently attracted attention was the use of mandated/programmed intermit-
tent bolus (PIB) doses, using the theoretical basis that increased local anesthetic volumes 
administered at one time that could increase perineural spread compared to volume/dose 
equivalent given as a basal infusion. Continuous adductor channel block requires a higher 
local basal anesthetic rate than the femoral nerve block. One study showed that although local 
anesthetic agents were given at relatively high rates (8 ml/h), the spread of local anesthetics 
remained limited. Subsequent studies involving healthy volunteers showed 0.2% ropivacaine 
at 8 ml/h as basal dose or intermittent bolus doses hourly gave the same sensory percep-
tions and quadriceps strength. Similar results are also reported for interscalene, femoral, and 
popliteal/sciatic catheters. For these reasons, the use of recurrent bolus doses can be reduced, 
unless recent RCTs may demonstrate the benefit of analgesia after thoracotomy at relatively 
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large levobupivacaine (15 ml) volumes via paravertebral catheters, every 6 h compared with 
continuous infusions [33, 42, 44, 46] (Table 6).
3.2.3. PCRA femoral nerve
The femoral nerve block is particularly indicated for pain control associated with unilateral 
anterior knee surgery. It is important to remember that the posterior obturator nerve provides 
an articular branch that supplies the posterior aspect of the knee, and this nerve may contrib-
ute to the pain that occurs in the posterior aspect of the knee after knee surgery, even though 
the femoral nerve block is effective. Therefore, additional sciatic nerve block is required if 
surgery is performed in the distal or posterior areas of the knee joint (e.g., on anterior or 
posterior cruciate ligament repair). It is not uncommon to require obturator nerve blocks and/
or sciatic nerve separately, in addition to the femoral nerve block after total knee replacement 
surgery. Often the pain experienced in the posterior knee is short and effectively controlled 
with a single injection block. Continuous femoral nerve block has been shown to improve 
postoperative outcomes of total knee arthroplasty, better than single-shot femoral nerve block 
and continuous epidural [33, 35–39, 46–49].
For early bolus injections, 0.25 ml/kg ropivacaine (0.25–0.5%) or bupivacaine (0.25–0.5%) 
as bolus injection for intra- and postoperative analgesia should be combined with general 
anesthesia. If used as a single anesthetic, a dose of 0.5 ml/kg is usually required. With this 
technique, breakthrough pain is rare, and patients feel comfortable when followed by a con-
tinuous dose of 0.1 ml/kg/h in children or 5 ml/h in adults with 0.25% ropivacaine or bupiva-
caine 0.25%. The use of PCRA can give a better effect. Increased PCRA requirements are often 
caused by improper catheter placement [33, 37, 38, 47, 48, 50–52] (Table 7).
Surgery 
procedure
Anesthesia intraoperative Postoperative PCRA
Medicine Continuous 
(ml/h)
Bolus on 
demand (ml)
Lockout 
interval 
(min)
Shoulder 
surgery
Interscalene catheter: 20–25 ml 
ropivacaine 0.5% or 15–20 ml 
bupivacaine 0.5% + epinephrine 
1:300,000 or 15–20 ml 
levobupivacaine 0.5%
Ropivacaine 0.2%
Bupivacaine 0.1–0.125%
Levobupivacaine 
0.1–0.2%
0–5
(child: 0.02 ml/
kg)
0–6
0–6
2–5
(child: 0.1 ml/
kg)
2–5
2–5
15–30
20–60
20–60
Upper and 
lower arm 
surgery
Infraclavicular or 
supraclavicular catheter: 
20–25 ml ropivacaine 0.5% 
or 15–20 ml bupivacaine 
0.5% + epinephrine 1:300,000 or 
15–20 ml levobupivacaine 0.5%
Ropivacaine 0.2%
Bupivacaine 0.1–0.125%
Levobupivacaine 
0.1–0.2%
0–5
(child: 0.02 ml/
kg)
0–6
0–6
2–5
(child: 0.1 ml/
kg)
2–5
2–5
15–30
20–60
20–60
Lower arm 
and hand 
surgery
Axillary: 15–20 ml 
bupivacaine 0.5% or 15–20 ml 
levobupivacaine 0.5%
Bupivacaine 0.25%
Levobupivacaine 
0.1–0.2%
0–10
0–10
2–10
2–10
30–60
30–60
Table 6. List of surgery, operative anesthesia, and postoperative analgesia.
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3.2.4. PCRA sciatic nerve
The sciatica nerve block is particularly indicated for pain management associated with unilat-
eral ankle, and in cases of lower leg operation. It is important to note that the saphenous nerves 
supply the medial aspect of the lower legs, ankles, and even the soles, which are branches of 
the femoral nerve. A single injection sciatica nerve block usually lasts relatively long, up to 
36 h and continuous nerve blocks may be indicated for special cases. Arthroplasty surgery on 
the ankle is a good example requiring a sciatica nerve block. If necessary, it can be combined 
with a saphenous nerve block. For early bolus injections, 0.25 ml/kg of ropivacaine 0.2–0.5% 
or 0.2–0.5% bupivacaine may be used as bolus injection for intra- and postoperative analgesia 
if block is combined with general anesthesia. If used as a single anesthetic, a dose of 0.5 ml/
kg is usually required. With this technique, breakthrough pain is very rare, and patients feel 
comfortable when followed by a continuous dose of 0.1 ml/kg/h in children or 5 ml/h in adults 
with 0.25% ropivacaine or bupivacaine 0.25%. The use of PCRA can give a better effect. High 
PCRA demands are often caused by improper catheter placement. In continuous popliteal 
sciatic block, local anesthetic administered as a programmed intermittent bolus (PIB) in con-
junction with PCA provided similar pain relief as a continuous infusion technique combined 
with PCA. However, the new dosing regimen reduced the need for additional PCA and the 
overall total consumption of local anesthetic [33, 36, 39, 46, 47, 49, 53, 54] (Table 8).
The home release of patients with a peripheral nerve catheter can be performed by various 
techniques such as the patient may be discharged with written instructions, the health worker 
Local anesthesia PCA setting PIB
Continuous (ml/h) Bolus 
(ml)
Lockout 
(min)
Volume 
(ml)
Interval 
(every)
Bupivacaine 0.1–0.25% 0–10 (child: 0.1 ml/kg//h) 5–10 30–60 — —
Ropivacaine 0.2–0.25% 2–8 (child: 0.1 ml/kg/h) 4–15 30–60 30
5–10
4 h
60–75 min
Levobupivacaine 0.125–0.25% 0–5 5–10 20–30 — —
Table 7. Setting of PCRA with catheter in femoral nerve.
Location of sciatic 
catheter
Local anesthesia Setting of PCA
Continuous (ml/h) Bolus on 
demand (ml)
Lockout interval 
(min)
Subgluteus Ropivacaine 0.2% 5–10
(child: 0.1 ml/kg/h)
5–10 30–60
Anterior Ropivacaine 0.2% 5–6 5–10 15–30
Popliteal Ropivacaine 0.2%
Levobupivacaine 0.125%
8–12
3–10
4–10
3–5
30–60
15–60
Table 8. PCRA setting with catheter in sciatic nerve (with or without femoral nerve block).
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may perform this procedure, or the patient’s caregiver (or sometimes the patient himself) can 
release the catheter with instructions provided by healthcare workers via telephone. Among 
these techniques, there are no procedures that are superior to others. Based on one of the 
surveys, 98% of patients feel comfortable removing their own catheters at home by giving 
instructions via telephone. Only 4% chose to return to health workers to remove catheters, 
and 43% felt comfortable with written instructions. Nonsterile gloves need to be given to 
patients if they intend to remove their own catheter at home. However, if the catheter is done 
by stitching fixation, then it should be removed only by medical personnel [33].
3.3. Field blocks
3.3.1. Transversus abdominis plane block (TAP block)
The TAP block is a novel technique for postoperative analgesia especially in the initial postop-
erative period. TAP block is a technique of locoregional anesthesia that involves the abdomi-
nal wall. This block was recently introduced for operations that involve the abdominal wall. 
The local anesthetic is placed in the plane between transversus abdominis muscle (TAM) and 
the internal oblique muscle (IOM), where there are sensorial afferent bundles of the nerves 
T7 to T12 and L1. The local anesthetic injected in the plane blocks the sensory afferents of all 
these nerves, providing pain relief for the entire anterior abdominal wall. Postoperative pain 
is an important issue with abdominoplasty and flank liposuction procedures. Bupivacaine 
hydrochloride (0.5%, 5 mg/ml, total dose, 2 mg/kg), 0.5% lignocaine, 0.375% bupivacaine 
20 ml, levobupivacaine to a maximum dose of 1 mg/kg each side, and 0.75% ropivacaine up to 
1.5 mg/kg (to a maximum dose of 150 mg) or other local anesthetics are injected bilaterally in 
the plane between the internal oblique muscles and the transversus abdominis muscles using 
a blunt needle, with or without USG guidance or injected directly during the surgical proce-
dure. Doses were increased in order to provide prolonged postoperative analgesia. Prolonged 
analgesic effect can be achieved by continuous blockade using catheter for drug delivery, 
but it is technically more demanding. For abdominal plastic surgery, TAP block to control 
postoperative pain administered after the flap resection and prior to the muscles plication. 
TAP block is used in esthetic abdominoplasty and postbariatric surgery. Compared between 
these two surgical procedures, TAP block gives better pain control in esthetic abdominoplasty 
than in postbariatric surgery. The larger amount of tissue resected in bariatric surgery gives 
greater stimulation of pain fiber. TAP block technique is associated with low postoperative 
requirements for morphine or other pain medication. It has got potential to substitute the use 
of intravenous opioid analgesics and hence to avoid its complications. It has been proved to 
cater significant analgesic effect especially below T10 up to L1 level [55–59].
The TAP block can be done either in preoperative or in postoperative, but because the abdom-
inal wall is intact preoperatively, it is preferred to be done before the surgery. The procedure 
must be done under extreme aseptic technique due to the risk of peritoneum penetration. The 
patient is positioned supine in both techniques [60]. There are two common techniques for 
TAP block [57–61]: (1) The blind TAP: the point of entry for the blind TAP is the lumber tri-
angle of Petit. The needle is inserted cephalad to the iliac crest and advanced until two distinct 
“pops” are felt as the needle transverses the external oblique and internal oblique muscles. 
To make the loss of resistance more appreciable, it is recommended to use a blunt needle. 
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(2) The ultrasound-guided TAP: the ultrasound probe is placed midway between the costal 
margin and the iliac crest to image in the transverse plane. The muscle layers are identified on 
the ultrasound image. The needle is gradually passed through the skin, subcutaneous tissue, 
EO, and IO, until it lies between the IO and TA—this is where the local anesthetic should be 
injected (Figure 4 and Table 9).
3.3.2. Continuous wound infusion system
Continuous wound infusion of local anesthetic will block the transmission of nociceptive 
stimuli from the wound surface, inhibit response of local inflammation to surgical wound, 
and suppress the spinal cord from systemic absorption of local anesthetics. Currently, this 
special wound infusion catheter can be inserted intra- and perioperatively into the wound. Liu 
et al. performed a meta-analysis on the available randomized controlled trials (RCTs). Forty-
four prospective randomized trials met the inclusion criteria for analysis. Overall results and 
Figure 4. Landmark (a), USG guide (b), and location of TAP injection (c) [60].
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all subgroup analysis showed that continuous local anesthetic infusion improved pain scores 
and decreased the need for supplemental narcotics. These results were statistically significant. 
Another randomized controlled trials had been done to examine the efficacy of this system in 
pain management, from the trials when compared with placebo, and this system can reduce 
the pain score as much as 33%. It is recommended that in the absence of neuraxial blocks or 
peripheral nerve blocks, wound infiltration should be performed whenever possible [6, 62–65].
To deliver continuous wound infusion, we can use a pain pump that has been studied in vari-
ous types of surgical procedures. Although pain pumps have been used in many surgical pro-
cedures, their use is relatively new in plastic surgery. The catheter is placed in the surgical site 
and local anesthetics are delivered to the site. Typically, using 0.25% bupivacaine or 0.25–0.5% 
ropivacaine can be infused continuously, bolused, or delivered via a patient-controlled deliv-
ery system. The 0.25% bupivacaine is usually infused at 2 ml/h for 48 h, delivering 120 mg per 
day. This is well below the recommended maximum dose of 400 mg in 24 h [6, 62, 63, 65, 66]. 
Baroody et al. [67], in a study of 16 patients with autologous latissimus dorsi breast reconstruc-
tion with historical controls, showed that continuous infusion of 0.25% bupivacaine, 2.08 ml/h, 
decreased pain level and significantly used less opioid in the postoperative period. They also 
observed that there was a reduction in PONV. Lu and Fine [68] published a study of the use of 
indwelling catheters for the continuous infiltration of bupivacaine using pain pump in 74 con-
secutive breast reductions and 74 consecutive tissue expander breast reconstruction patients, 
and each group was compared with patients receiving conventional analgesia. Pain and aver-
age pain score was significantly lower, but do not eliminate pain, in the pain pump group 
than in the comparison group, as were cumulative amounts of pain medications. There were 
no statistically significant differences in the number of complications or in the rate of PONV.
One study found that there was a 91–93% overall patient satisfaction with the pain pumps, 
which was statistically significantly greater than the saline group satisfaction rate. There 
was significant improvement in patient satisfaction in the bupivacaine group, and their PCA 
narcotic use was decreased in the first 48 h [62]. Giordano et al. [69] in their study about 
abdominal donor site analgesia in patients undergoing free lower abdominal flap breast 
reconstruction comparing pain pump use vs. control found a significantly decreased use of 
opioids after using pain pump vs. control and a trend toward reduction in the antiemetic 
medicament use and shorter hospital stay. One thing to be kept in mind is that the surgeon 
and anesthetist must be aware of the risk of local anesthetic systemic toxicity, although it is 
very rare. Care must be taken not to exceed the daily maximum dose of local anesthetics, 
Complications Contraindications
Absolute Relative
Local anesthetic toxicity Patient refusal Coagulopathy
Intraperitoneal injection Allergy to local anesthetic Surgery at injection site
Bowel injury Localized infection over injection point
Hepatic injury
Table 9. Complication and contraindication of TAP block [60].
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including the amount infiltrated with surgery as well as the total amount infused via the pain 
pump [62, 66, 70, 71]. Even though pain pump is popular, the cost-effectiveness of these pain 
pumps needs further investigation.
3.3.3. Tumescent analgesia
Tumescent analgesia (TA) is a part of local anesthesia using a very dilute local anesthetic, which 
delivered subcutaneously in a large volume of fluid. In plastic surgery, TA can be used alone 
or with sedation to achieve intraoperative analgesia. It can also be used along with neuraxial 
analgesia or general anesthesia to get postoperative analgesia and lower intraoperative anes-
thesia. This technique was used most commonly in liposuction, but can also be used in other 
plastic surgeries such as subcutaneous mass excisions and scar revisions, excisional body con-
touring (abdominoplasty, body lifts, arm lifts, and thigh lifts), breast augmentation, reduction, 
mastopexy, gynecomastia, and capsular contracture revision, mastectomy, burn excision and 
skin grafting, skin procedures (dermabrasion and laser resurfacing), face and neck lifts, and hair 
grafting. TA can be used in other procedures to decrease intra- and postoperative pain, allowing 
less use or elimination of anesthesia and opioids. The addition of diluted epinephrine in TA leads 
to vasoconstriction that can significantly lower the blood loss, minimizing bruising, and post-
operative soreness. The advantages of TA are fewer narcotic use, less sedation, and less general 
anesthesia needed, faster recovery, and earlier discharge. These advantages could prevent the 
use of general anesthesia and decrease the possibility of pulmonary thromboembolism [72–76].
TA fluid formula is based on 1000 ml of either 0.9% saline or ringer lactate solution. When 
the tumescent technique is used with general anesthesia, the concentration of epinephrine is 
1:1,000,000. This solution can be added with bupivacaine, lidocaine, hyaluronidase, or triam-
cinolone 10 mg/L and has also been used to decrease ecchymosis and edema, but there is a 
little comparative evidence regarding its usefulness. Lidocaine is most commonly used as a 
local anesthetic in TA. The recommended maximum dose of lidocaine used for TA is differ-
ent compared to a traditional local infiltration (Table 10). Bupivacaine can be used alone or 
with lidocaine. A patient who received bupivacaine has a shorter hospital stay. If the patient 
is allergic to lidocaine, prilocaine can be used instead. The recommended dose of prilocaine 
of 8 mg/kg for small volume liposuction and doses up to 35 mg/kg is safe. Patient should be 
monitored for 12 h after administration of prilocaine to evaluate if there are methemoglobin-
emia sign and symptoms such as a headache, dyspnea, lightheadedness, weakness, confu-
sion, delirium, palpitations, chest pain, cyanosis, dysrhythmias, seizures, coma, acidosis, and 
cardiac or neurologic ischemia and should be precautious in liver patients [72–76].
Tumescent fluid is administered with an 18G long spinal needle for a small procedure or blunt 
infiltration cannula for the larger procedures. Before TA is given, lidocaine 1% and 1:100,000 
epinephrine is injected intradermally to decrease skin bleeding. Plasma peak of lidocaine is 
seen 10–14 h after its administration, but in the highly vascularized area, the peak of lidocaine 
reaches in 6 h. Monitoring should be extended in a patient who receives high dose of lidocaine. 
Lidocaine toxicity is suspected in a patient with restlessness, drowsiness, light-headedness, 
metallic taste, tinnitus, slurred speech, and numbness in lips and tongue, shivering, muscle 
twitching, tremors followed by convulsion, central nervous system depression, coma, respira-
tory depression, and cardiac arrest. If signs of toxicity appear, stop infusion of fluids with 
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local anesthetics, protect airway and oxygenation, call for help, and give benzodiazepines if 
seizures happened. Manage arrhythmia based on ACLS guidelines but avoid lidocaine, give 
lipid emulsion therapy if cardiac or neurological event persists [70–73].
Discomfort during injection of lidocaine can be decreased with the addition of sodium bicar-
bonate. Sodium bicarbonate is contraindicated as addition to bupivacaine because it can pre-
cipitate the solution. High volumes of TA infusion have a risk of intravascular fluid overload 
with cardiac and pulmonary effect. In a patient with cardiac, pulmonary, or renal pathology, 
the pros and cons of TA must be considered with the limitation of the injected volume. Patient 
with high-volume TA can have a risk of mild hyponatremia and hypokalemia, lowering 
body temperature with impaired thermoregulatory system, and acute nerve compression. 
Administration of TA at 37°C can decrease the risk of hypothermia. In a patient with nerve 
compression, this condition can be resolved after giving diuretics [72, 73].
4. Conclusion
The patients who undergo plastic surgery procedure can experience various types of pain, 
including background pain, breakthrough pain, and procedural pain. Treatment for each type 
of plastic surgery and resulted pain requires a specific approach and must be individualized 
to the patient. There are three main techniques in acute pain management postoperatively, 
such as systemic analgesia, regional analgesia, and local/topical analgesia. Currently, pain 
management through intravenous injection or continuous central neuraxial and peripheral 
nerve block is more controllable and safer since the invention of pain pump, which commonly 
use the principal of patient-controlled analgesia. Multimodal treatment seems to have sig-
nificant benefits, postoperative dosing becomes more complex, and adverse drug interactions 
and drug overdose become more likely. There is some combination that has demonstrated a 
good effect in multimodal analgesia. PCA intravenous, patient-controlled epidural analgesia 
(PCEA) and patient-controlled regional analgesia (PCRA) can be combined with other pain 
Medication Concentration (%) Maximum dose range
Without epinephrine 
(mg/kg) for TA
With epinephrine 
(mg/kg) for TA
“Traditional local infiltration” 
dose with and without 
epinephrine (mg/kg)
Lidocaine 1.0 30–60 90–120 4–7
Bupivacaine 0.25 120–240 180 2.5–3
Ropivacaine 0.2 120–360 120–360 2.7
Mepivacaine 1.0 45–90 120 4–7
Etidocaine 0.5 120–180 180 4–5.5
Epinephrine (1:1000) 1:1000 0.5–2 ml of 1:1000
Sodium bicarbonate 
(8.4%)
8.4 10–12.5 ml —
Table 10. Common tumescent analgesia concentration and dose.
Anesthesia Topics for Plastic and Reconstructive Surgery122
killers, such as paracetamol, NSAIDs, alpha-2-delta modulators (gabapentin and pregabalin), 
N-methyl-D-aspartate (NMDA) antagonists (ketamine and magnesium), alpha-2-agonists 
(clonidine and dexmedetomidine), TAP block, continuous wound infusion system using pain 
pump, and tumescent analgesia with local anesthetic.
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